Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 Oct;28(4):500–503. doi: 10.1128/aac.28.4.500

Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.

S T Donta, L A Lembke
PMCID: PMC180291  PMID: 4073872

Abstract

Patients receiving gentamicin or tobramycin were studied to determine whether there were differences in the urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) between the two groups. The average daily increases in NAG excretion were significantly higher in the group receiving gentamicin. In individual patients, the best correlation with nephrotoxicity was with high initial rates of NAG excretion. If abnormally high initial rates of increase can serve as a prognosticator of nephrotoxicity, it may be possible to alter aminoglycoside therapy and to avoid renal damage.

Full text

PDF
500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brinker K. R., Bulger R. E., Dobyan D. C., Stacey T. R., Southern P. M., Henrich W. L., Cronin R. E. Effect of potassium depletion on gentamicin nephrotoxicity. J Lab Clin Med. 1981 Aug;98(2):292–301. [PubMed] [Google Scholar]
  2. Feig P. U., Mitchell P. P., Abrutyn E., Brock S. M., Carney W. R., Graeber C. W., Horak E., Lyons R. W., Maher J. F. Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin. J Antimicrob Chemother. 1982 Sep;10(3):217–226. doi: 10.1093/jac/10.3.217. [DOI] [PubMed] [Google Scholar]
  3. Fong I. W., Fenton R. S., Bird R. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study. J Antimicrob Chemother. 1981 Jan;7(1):81–88. doi: 10.1093/jac/7.1.81. [DOI] [PubMed] [Google Scholar]
  4. Halkin H., Lidji M., Rubinstein E. The influence of endotoxin-induced pyrexia on the pharmacokinetics of gentamicin in the rabbit. J Pharmacol Exp Ther. 1981 Feb;216(2):415–418. [PubMed] [Google Scholar]
  5. Kumin G. D. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA. 1980 Oct 17;244(16):1808–1810. [PubMed] [Google Scholar]
  6. Kunin C. M., Chesney R. W., Craig W. A., England A. C., DeAngelis C. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Pediatrics. 1978 Nov;62(5):751–760. [PubMed] [Google Scholar]
  7. LEABACK D. H., WALKER P. G. Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase. Biochem J. 1961 Jan;78:151–156. doi: 10.1042/bj0780151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mirhij N. J., Roberts R. J., Myers M. G. Effects of hypoxemia upon aminoglycoside serum pharmacokinetics in animals. Antimicrob Agents Chemother. 1978 Sep;14(3):344–347. doi: 10.1128/aac.14.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Perry W., Jenkins M. V., Stamp T. C. Lysosomal enzymes and pancreatitis during rifampicin therapy. Lancet. 1979 Mar 3;1(8114):492–492. doi: 10.1016/s0140-6736(79)90845-6. [DOI] [PubMed] [Google Scholar]
  10. Price R. G., Dance N., Richards B., Cattell W. R. The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta. 1970 Jan;27(1):65–72. doi: 10.1016/0009-8981(70)90375-x. [DOI] [PubMed] [Google Scholar]
  11. Prince R. A., Ling M. H., Hepler C. D., Rainville E. C., Kealey G. P., Donta S. T., LeFrock J. L., Kowalsky S. F. Factors associated with creatinine clearance changes following gentamicin therapy. Am J Hosp Pharm. 1980 Nov;37(11):1489–1495. [PubMed] [Google Scholar]
  12. Rinderknecht H., Renner I. G., Koyama H. H. Lysosomal enzymes in pure pancreatic juice from normal healthy volunteers and chronic alcoholics. Dig Dis Sci. 1979 Mar;24(3):180–186. doi: 10.1007/BF01308426. [DOI] [PubMed] [Google Scholar]
  13. Schentag J. J., Gengo F. M., Plaut M. E., Danner D., Mangione A., Jusko W. J. Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides. Antimicrob Agents Chemother. 1979 Oct;16(4):468–474. doi: 10.1128/aac.16.4.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schentag J. J., Plaut M. E., Cerra F. B. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrob Agents Chemother. 1981 May;19(5):859–866. doi: 10.1128/aac.19.5.859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schwartz S. N., Pazin G. J., Lyon J. A., Ho M., Pasculle A. W. A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects. J Infect Dis. 1978 Oct;138(4):499–505. doi: 10.1093/infdis/138.4.499. [DOI] [PubMed] [Google Scholar]
  16. Smith C. R., Lipsky J. J., Laskin O. L., Hellmann D. B., Mellits E. D., Longstreth J., Lietman P. S. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980 May 15;302(20):1106–1109. doi: 10.1056/NEJM198005153022002. [DOI] [PubMed] [Google Scholar]
  17. Wellwood J. M., Price R. G., Ellis B. G., Thompson A. E. A note on the practical aspects of the assay of N-acetyl-beta-glucosaminidase in human urine. Clin Chim Acta. 1976 May 17;69(1):85–91. doi: 10.1016/0009-8981(76)90475-7. [DOI] [PubMed] [Google Scholar]
  18. Wellwood J. M., Price R. G., Ellis B. G., Thompson A. E. A note on the practical aspects of the assay of N-acetyl-beta-glucosaminidase in human urine. Clin Chim Acta. 1976 May 17;69(1):85–91. doi: 10.1016/0009-8981(76)90475-7. [DOI] [PubMed] [Google Scholar]
  19. Zaske D. E., Cipolle R. J., Strate R. G., Dickes W. F. Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients. Am J Obstet Gynecol. 1981 Apr 15;139(8):896–900. doi: 10.1016/0002-9378(81)90954-6. [DOI] [PubMed] [Google Scholar]
  20. Zaske D. E., Cipolle R. J., Strate R. J. Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function. Surgery. 1980 Feb;87(2):164–169. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES